OB-001 is a highly selective and effective inhibitor of two key efflux pumps (P-gp and BCRP), which are present both on the ...
Company plans to initiate clinical development of tonabersat in 2027, exploring a potential non-invasive treatment option for ...
Closed-loop platform integrates generative AI, biological modelling and automated experiments as XtalPi advances six ...
QIAGEN N.V. announced new artificial intelligence (AI) capabilities to help researchers analyze complex biological and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results